Holdings
Ishara Investments LP
As of Sep 30, 2026, Ishara Investments LP reported 36 positions worth US$114M. Largest: Travere Therapeutics, Inc., Cytokinetics, Incorporated and BridgeBio Pharma, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Travere Therapeutics, Inc. | 145K | US$8.54M | +63,000 | Sep 30, 2026 |
| Cytokinetics, Incorporated | 128K | US$8.44M | +95,200 | Sep 30, 2026 |
| BridgeBio Pharma, Inc. | 100K | US$6.58M | +42,600 | Sep 30, 2026 |
| ACADIA Pharmaceuticals Inc. | 320K | US$6.45M | −90,000 | Sep 30, 2026 |
| Tarsus Pharmaceuticals, Inc. | 70,000 | US$5.5M | new | Sep 30, 2026 |
| PTC Therapeutics, Inc. | 80,000 | US$5.18M | new | Sep 30, 2026 |
| Praxis Precision Medicines, Inc. | 17,000 | US$4.95M | −5,550 | Sep 30, 2026 |
| Vera Therapeutics, Inc. | 150K | US$4.84M | +140K | Sep 30, 2026 |
| Arcutis Biotherapeutics, Inc. | 180K | US$4.76M | new | Sep 30, 2026 |
| Annexon, Inc. | 1.12M | US$4.74M | +300K | Sep 30, 2026 |